Levetiracetam Aristo (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which plays a key role in regulating neurotransmitter release. This binding modulates vesicle exocytosis, leading to reduced release of excitatory neurotransmitters and stabilisation of neuronal firing, thereby lowering the likelihood of seizure activity.

The specific dose of Levetiracetam Aristo is determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Healthcare professionals tailor the regimen to achieve optimal seizure control while minimising side effects.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians should evaluate the potential benefits against possible risks and discuss options with the patient. If treatment is necessary, the prescriber will monitor both mother and child closely.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Levetiracetam differs from many older antiepileptics because it has a unique mechanism (SV2A binding) and a relatively low potential for drug‑drug interactions. It is often chosen for patients who need a medication with a simple dosing schedule and fewer metabolic concerns compared with enzyme‑inducing agents.

Levetiracetam Aristo should be stored at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, direct sunlight and excessive heat to maintain stability and potency.

Levetiracetam Aristo is taken orally, usually as a tablet. It can be swallowed whole with water, and dosing may be once or twice daily depending on the prescriber’s instructions and the patient’s clinical response.

Serious risks include severe allergic reactions such as Stevens‑Johnson syndrome, psychiatric effects like suicidal thoughts or major depression, and rare blood disorders (e.g., leukopenia). Patients should be instructed to seek immediate medical attention if they notice rash, mood changes, or unusual bleeding.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is also advised for patients with severe renal impairment who may require dose adjustment, and for those with a history of serious psychiatric disorders.